Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-004839
Filing Date
2018-02-21
Accepted
2018-02-21 17:16:34
Documents
1
Period of Report
2018-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4217
  Complete submission text file 0000899243-18-004839.txt   5630
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON ST., SUITE 3310 PRUDENTIAL TOWER C/O AJU IB INVESTMENT BOSTON MA 02199
Business Address
Sullivan Timothy Eugene (Reporting) CIK: 0001707000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 18629461